HOLLY LAVENDER: Open Payments
NPI 1184197899 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 38 payments from 16 companies in 2025. Trend: 2023 $67 · 2024 $616 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $160 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $92 |
| Amgen Inc. | 6 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| Novo Nordisk Inc | 4 | $73 |
| Daiichi Sankyo Inc. | 4 | $66 |
| Alnylam Pharmaceuticals Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| AngioDynamics, Inc. | 1 | $23 |
Products named: SAPIEN 3 Ultra RESILIA, LifeVest, REPATHA, Kerendia, Wegovy, INJECTAFER, ONPATTRO, LEQVIO.
Industry payments across OK — which companies pay providers there.
